Tandem Diabetes Care, Inc. recalls
9 notices naming Tandem Diabetes Care, Inc. as the recalling firm, since April 23, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Tandem Diabetes Care, Inc.: Tandem Mobi Insulin Pump
Hazard (FDA): Tandem Diabetes Care, Inc. ( Tandem ) has identified that certain Tandem Mobi insulin pumps may generate false-positive occlusion alarms when no actual insulin flow obstruction is present. Investigation determined that…
FDAMedical devices
Tandem Diabetes Care, Inc.: Brand Name: Tandem t:slim mobile application Product Name: t:slim Mobile Application
Hazard (FDA): A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous…
FDAMedical devices
Tandem Diabetes Care, Inc.: Tandem pumps are battery-operated infusion pumps capable of both basal and bolus…
Hazard (FDA): The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when it should instead…
FDAMedical devices
Tandem Diabetes Care, Inc.: Tandem Mobi Insulin Pump: Description/Catalog: Tandem insulin pumps are battery-operated…
Hazard (FDA): Insulin pump includes a vibration motor that gives tactile feedback for any alerts, alarms, or malfunctions. Pump may exhibit false vibration motor failure due to a software issue causing Malfunction 12: "Pump cannot…
FDAMedical devices
Tandem Diabetes Care, Inc.: t:slim X2 insulin pump with Interoperable Technology
Hazard (FDA): A software defect in versions 7.9.0.1 and 7.10.1 of the pump software for Tandem t:slim X2 and version 7.9.0.1 of the Tandem Mobi pump with Control-IQ+ technology that are paired with a G7 sensor may result in an…
FDAMedical devices
Tandem Diabetes Care, Inc.: t:slim X2 Insulin Pump with Interoperable Technology
Hazard (FDA): an app defect that occurs when the phone is set to a right-to-left language, which causes app-pump pairing issues and graphical defects, which can potentially lead to incorrect therapy decisions and subsequent…
FDAMedical devices
Tandem Diabetes Care, Inc.: Battery Operated infusion pumps. t:slim X2 G5
Hazard (FDA): Insulin pumps manufactured with speakers from Revision A and B may malfunction ("Malfunction 16") which prevents audible alerts and causes the pumps to become inoperable and stop infusing insulin which could result in…
FDAMedical devices
Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps
Hazard (FDA): Potential speaker-related issue that can trigger an error resulting in a discontinuation of insulin delivery
FDAMedical devices
Tandem Diabetes Care, Inc.: t:slim X2 Insulin Pump with Interoperable Technology and 1 more
Hazard (FDA): A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated…
FDAMedical devices